Health experts are alarmed as Republicans degrade the country’s pivotal HIV programs — and break promises made during Trump’s ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...

Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

Irish minister describes AMR as ‘one of the greatest global health challenges of our time’ as the government seeks to ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from the pivotal ...

Private sector leaders, philanthropists, and global health experts convened today at the B20 Global Health Breakout, held on the margins of the G20 Leaders' Summit, to spotlight a new wave of ...

Positive results mark an important step forward in efforts to develop effective treatments for children with drug-resistant TB COPENHAGEN, Denmark, Nov. 19, 2025 /PRNewswire/ -- New interim data from ...

Sanam Saaber is taking the legal reins of Axonius, a threat detection and mitigation platform that has raised $865 million.

Researchers in the TB Alliance informed the Union Conference on Lung Health in Copenhagen that Sorbequiline, a new antibiotic ...

Medicaid provides health coverage for disabled and low-income populations, and the ACA expansion gives states the option to extend coverage to adults with up to 138% of the federal poverty line.

About 1,000 doses of Gilead Sciences Inc's drug lenacapavir were delivered to Zambia and Eswatini last Thursday, U.S. and ...